Aptinyx to Present at Cantor Fitzgerald Global Healthcare Conference
EVANSTON, Ill., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that Norbert Riedel, Ph.D., president …